Conclusion
These findings suggest that ATRA can induce severe thrombocytosis, as a potential side effect of treatment, in APL patients through stimulating the productions of different cytokines, especially IL-6, from APL cells under differentiation. However, further studies and more information are needed to confirm this conclusion and provide criteria for its management.